Flares in chronic hepatitis B patients induced by the host or the virus?: Relation to treatment response during Peg-interferon α-2b therapy

被引：0
|
作者：
Flink, HJ
Sprengers, D
Hansen, BE
Verhey, E
van Zonneveld, M
de Man, RA
Schalm, SW
Janssen, HLA
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2005年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
487
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [1] Flares in chronic hepatitis B patients induced by the host or the virus?: Relation to treatment response during Peg-interferon α-2b therapy
    Flink, HJ
    Sprengers, D
    Hansen, BE
    van Zonneveld, M
    de Man, RA
    Schalm, SW
    Janssen, HLA
    GUT, 2005, 54 (11) : 1604 - 1609
  • [2] Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response
    ter Borg, Martijn J.
    van Zonneveld, Monika
    Zeuzem, Stefan
    Senturk, Hakan
    Akarca, Ulus S.
    Simon, Christopher
    Hansen, Bettina E.
    Haagmans, Bart L.
    de Man, Robert A.
    Schalm, Solko W.
    Janssen, Harry L. A.
    HEPATOLOGY, 2006, 44 (03) : 721 - 727
  • [3] PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon A or interferon α-2b plus ribavirin therapy.
    Sulkowski, M
    Rothstein, KD
    Stein, L
    Godofsky, E
    Shoultz, D
    Hudnall, R
    Huff, M
    Dieterich, D
    HEPATOLOGY, 2001, 34 (04) : 419A - 419A
  • [4] Update on PEG-Interferon α-2b as Adjuvant Therapy in Melanoma
    Di Trolio, Rossella
    Simeone, Ester
    Di Lorenzo, Giuseppe
    Grimaldi, Antonio Maria
    Romano, Anna
    Ayala, Fabrizio
    Caraco, Corrado
    Mozzillo, Nicola
    Ascierto, Paolo A.
    ANTICANCER RESEARCH, 2012, 32 (09) : 3901 - 3909
  • [5] Treatment of chronic hepatitis delta with PEG-interferon alpha-2b.
    Castelnau, C
    Gordien, E
    Boyer, N
    Martinot, M
    Deny, P
    Marcellin, P
    HEPATOLOGY, 2004, 40 (04) : 675A - 675A
  • [6] Comparative analysis of Peg-Interferon alpha-2b and lamivudine in the treatment of chronic hepatitis B patients
    Sidiropoulos, I
    Koliouskas, D
    Masmanidou, M
    Mandraveli, K
    Lazaraki, G
    Dokas, S
    Ziakas, A
    HEPATOLOGY, 2002, 36 (04) : 626A - 626A
  • [7] Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B:: HBsAg loss is associated with HBV genotype
    Flink, HJ
    van Zonneveld, M
    Hansen, BE
    de Man, RA
    Schalm, SW
    Janssen, HLA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02): : 297 - 303
  • [8] Reversible alopecia universalis secondary to PEG-interferon α-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
    Kartal, Elif Doyuk
    Alpat, Saygin Nayman
    Ozgunes, Ilhan
    Usluer, Gaye
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (09) : 817 - 820
  • [9] Bilateral AION after the combined therapy of hepatitis C with PEG-interferon α2B and ribavirin
    Kirchhoff, A
    Kirchhoff, U
    Lafrenz, M
    Guthoff, R
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2004, 221 (09) : 791 - 793
  • [10] In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection
    Sprengers, D.
    van der Molen, R. G.
    Binda, R.
    Kusters, J. G.
    de Man, R. A.
    Niesters, H. G. M.
    Schalm, S. W.
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 743 - 749
12345